For years , doctors have searched for viable therapies for treatment-resistant depression . Now points to esketamine therapy, given typically intravenously , appears to offer real breakthrough for patients IV copyright therapy who haven’t responded from traditional antidepressants . While primarily considered an experimental intervention, prelimi